TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 4 | -3 | 6 | 6 | 1 | 6 | 3 |
| P | %wins | 100 | 50 | 50 | 100 | 50 | 100 | 75 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/26/11 16:37 | 5/25/11 | SRLS | Seracare Life Sciences Inc | Health | Diagn | In Vitro & In Vivo Diagnostic | Vogt Susan L N | MA | DO | P,CEO,Di | P | 42 | 3.51 | 0 | 12 | 7 | 190 | D | 209 | -28 | -13 | -14 | -11 | -10 | -8 | -3 | 3 | 4 | 16 | 0 | -17 | ||
8/17/10 16:17 | 8/16/10 | SRLS | Seracare Life Sciences Inc | Health | Diagn | In Vitro & In Vivo Diagnostic | Vogt Susan L N | MA | DO | P,CEO,Di | P.m | 52 | 3.45 | 0 | 15 | 18 | 98 | D | -20 | 46 | -1 | -33 | -3 | -12 | -12 | 4 | 4 | -9 | -4 | 11 | 19 | 6 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |